Jove
Visualize
Contact Us

Related Experiment Videos

[Etiologic considerations regarding superior vena cava syndrome].

J A González Fajardo1, M García Yuste, S Flórez Peláez

  • 1Departamento de Cirugía, Hospital Clínico Universitario, Valladolid.

Anales De Medicina Interna (Madrid, Spain : 1984)
|November 1, 1991
PubMed
Summary

The causes of Superior Vena Cava Syndrome have shifted, with malignancy now being the primary driver. Accurate histologic diagnosis is crucial before treatment due to potential benign causes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design of a New Risk Score in Critical Limb Ischaemia: The ERICVA Model.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2015
Same author

[Gastrointestinal stromal tumors (GISTs): clinical aspects].

Revista espanola de enfermedades digestivas·2007
Same author

[Spermatic cord liposarcoma. Association with prostate cancer. Report of a case and review of literature].

Actas urologicas espanolas·2005
Same author

[Adult Wilms' tumor].

Actas urologicas espanolas·2004
Same author

[Giant retroperitoneal liposarcoma].

Actas urologicas espanolas·2003
Same author

Structure of general thoracic surgery in Europe.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2001
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Medical Science
  • Oncology
  • Vascular Medicine

Context:

  • The etiology of Superior Vena Cava Syndrome (SVCS) has evolved significantly over the past century.
  • Historically, aortic aneurysms, mediastinitis, and malignant tumors were leading causes.
  • Current literature indicates a predominant role of malignancy (85-90%) in SVCS obstruction.

Purpose:

  • To review the changing etiological trends of Superior Vena Cava Syndrome.
  • To highlight the increasing prevalence of malignant causes and the emergence of iatrogenic foreign bodies as a cause of thrombosis.
  • To emphasize the importance of histologic diagnosis prior to treatment initiation.

Summary:

  • A literature review reveals a marked shift in the causes of Superior Vena Cava Syndrome.

Related Experiment Videos

  • Malignancy is now the dominant etiology (85-90%), with small cell lung carcinoma being the most common.
  • Benign conditions, including iatrogenic foreign bodies, account for 10-15% and necessitate careful diagnostic evaluation.

    • Impact:

    • Underscores the critical need for accurate histologic diagnosis in managing Superior Vena Cava Syndrome.
    • Informs clinical practice regarding the differential diagnosis of SVCS, considering both malignant and benign etiologies.
    • Highlights the evolving landscape of SVCS causes, including the impact of medical interventions.